Fluoxetine scaffold to design tandem molecular antioxidants and green catalysts.
Giovanni RibaudoMarco BortoliAlberto OngaroErika OselladoreAlessandra GianoncelliGiuseppe ZagottoLaura OrianPublished in: RSC advances (2020)
Fluoxetine finds application in the treatment of depression and mood disorders. This selective serotonin-reuptake inhibitor (SSRI) also contrasts oxidative stress by direct ROS scavenging, modulation of the endogenous antioxidant defense system, and/or enhancement of the serotonin antioxidant capacity. We synthesised some fluoxetine analogues incorporating a selenium nucleus, thus expanding its antioxidant potential by enabling a hydroperoxides-inactivating, glutathione peroxidase (GPx)-like activity. Radical scavenging and peroxidatic activity were combined in a water-soluble, drug-like, tandem antioxidant molecule. Selenofluoxetine derivatives were reacted with H 2 O 2 in water, and the mechanistic details of the reaction were unravelled combining nuclear magnetic resonance (NMR), electrospray ionisation-mass spectrometry (ESI-MS) and quantum chemistry calculations. The observed oxidation-elimination process led to the formation of seleninic acid and cinnamylamine in a trans -selective manner. This mechanism is likely to be extended to other substrates for the preparation of unsaturated cinnamylamines.
Keyphrases
- oxidative stress
- mass spectrometry
- magnetic resonance
- water soluble
- liquid chromatography
- dna damage
- anti inflammatory
- ms ms
- high resolution
- molecular dynamics
- hydrogen peroxide
- ischemia reperfusion injury
- sleep quality
- gas chromatography
- diabetic rats
- bipolar disorder
- capillary electrophoresis
- induced apoptosis
- multiple sclerosis
- depressive symptoms
- cell death
- high performance liquid chromatography
- molecular dynamics simulations
- highly efficient
- molecular docking
- risk assessment
- structure activity relationship
- reactive oxygen species
- tandem mass spectrometry
- tissue engineering
- solid state
- computed tomography
- smoking cessation
- adverse drug
- drug discovery
- endoplasmic reticulum stress